Journal
CURRENT OPINION IN ORGAN TRANSPLANTATION
Volume 17, Issue 6, Pages 681-687Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOT.0b013e32835a34a6
Keywords
cellular therapy; growth factors; myocardial infarct; scaffolds; tissue engineering
Categories
Funding
- European Union [229239]
Ask authors/readers for more resources
Purpose of review Present an overview of last year's advances in stem cell delivery for cardiac tissue engineering. Recent findings Several promising novel biomaterial platforms to improve myocardial tissue repair/regeneration and local neovascularization using cellular therapy have been developed. Summary Still today, a clear statement on cellular therapy efficacy cannot be made but nonetheless, as we describe in this review, several improved in-vivo applications have already been initiated. The newest tissue engineering platforms have basically two main objectives: to improve low cell engraftment and viability into the hostile environment of the infarcted tissue; and to promote neoformation of functional myocardial tissue. With the idea to solve these issues many groups are presently working on the association of stem cells with novel biomaterials, providing an initial appropriate microenvironment (scaffold) for successful cell transplantation, proper differentiation and improved cardiac function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available